Molecular Neuropsychology: Creation of Test-Specific Blood Biomarker Algorithms

Abstract

Background: Prior work on the link between blood-based biomarkers and cognitive status has largely been based on dichotomous classifications rather than detailed neuropsychological functioning. The current project was designed to create serum-based biomarker algorithms that predict neuropsychological test performance. Methods: A battery of neuropsychological measures was administered. Random forest analyses were utilized to create neuropsychological test-specific biomarker risk scores in a training set that were entered into linear regression models predicting the respective test scores in the test set. Serum multiplex biomarker data were analyzed on 108 proteins from 395 participants (197 Alzheimer patients and 198 controls) from the Texas Alzheimer's Research and Care Consortium. Results: The biomarker risk scores were significant predictors (p < 0.05) of scores on all neuropsychological tests. With the exception of premorbid intellectual status (6.6%), the biomarker risk scores alone accounted for a minimum of 12.9% of the variance in neuropsychological scores. Biomarker algorithms (biomarker risk scores and demographics) accounted for substantially more variance in scores. Review of the variable importance plots indicated differential patterns of biomarker significance for each test, suggesting the possibility of domain-specific biomarker algorithms. Conclusions: Our findings provide proof of concept for a novel area of scientific discovery, which we term ‘molecular neuropsychology'.

Total Cholesterol and Neuropsychiatric Symptoms in Alzheimer's Disease: The Impact of Total Cholesterol Level and Gender

“…This platform has been utilized in the development of blood-based algorithms for the detection of Alzheimer's [25] and the development of test specific blood-based algorithms of cognitive impairment [26]. For the current study total cholesterol was the biomarker of interest as our earlier work found that components of HDL, LDL and triglycerides individually were not significant predictors of NPS.…”

Serum-based Protein Profiles of Alzheimer’s Disease and Mild Cognitive Impairment in Elderly Hispanics

“…In fact, in an independent study we have begun to examine blood-based profiles of amnestic versus nonamnestic MCI. Additionally, in our prior work one can incorporate select cognitive screens (single instruments) to the blood-based profiles to refine the algorithms, which we have termed molecular neuropsychology [62]. It is likely that this approach will significantly improve upon the MCI algorithm.…”

Combining Select Neuropsychological Assessment with Blood-Based Biomarkers to Detect Mild Alzheimer's Disease: A Molecular Neuropsychology Approach

“…This algorithm was later refined to 8 serum-based proteins, which yielded an overall accuracy of 98% in discriminating AD cases from healthy controls [6]. The top two serum-based biomarkers for the AD profile included tumor necrosis factor-alpha (TNFα) and interleukin 7(IL7) [7]. …”

“…Another pro-inflammatory biomarker, IL7, which is involved in the development and differentiation of both T cells and B cells, has been linked to AD [14]. Specifically, IL7 accounted for more variance in those with AD across several studies that sought to identity biomarkers of cognitive dysfunction [5, 7, 15]. …”

“…Prior work has sought to identify serum-based biomarker algorithms of specific neuropsychological functioning [7]. This work, termed Molecular Neuropsychology, provided an initial demonstration of the utility of algorithms combining blood-based biomarkers with neuropsychological functioning and also identified biomarker profiles associated with specific cognitive domains [7].…”